These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19556315)

  • 1. The development of patient-reported outcome indices for multiple sclerosis (PRIMUS).
    Doward LC; McKenna SP; Meads DM; Twiss J; Eckert BJ
    Mult Scler; 2009 Sep; 15(9):1092-102. PubMed ID: 19556315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International development of the patient-reported outcome indices for multiple sclerosis (PRIMUS).
    McKenna SP; Doward LC; Twiss J; Hagell P; Oprandi NC; Fisk J; Grand'Maison F; Bhan V; Arbizu T; Brassat D; Kohlmann T; Meads DM; Eckert BJ
    Value Health; 2010 Dec; 13(8):946-51. PubMed ID: 20667058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring quality of life in multiple sclerosis: not as simple as it sounds.
    Nicholl L; Hobart JC; Cramp AF; Lowe-Strong AS
    Mult Scler; 2005 Dec; 11(6):708-12. PubMed ID: 16320732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychometric properties of the SDM-Q-9 questionnaire for shared decision-making in multiple sclerosis: item response theory modelling and confirmatory factor analysis.
    Ballesteros J; Moral E; Brieva L; Ruiz-Beato E; Prefasi D; Maurino J
    Health Qual Life Outcomes; 2017 Apr; 15(1):79. PubMed ID: 28431587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interpreting scores on multiple sclerosis-specific patient reported outcome measures (the PRIMUS and U-FIS).
    Twiss J; Doward LC; McKenna SP; Eckert B
    Health Qual Life Outcomes; 2010 Oct; 8():117. PubMed ID: 20937112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic approach to analyse health-related quality of life in multiple sclerosis: the GEDMA study.
    Morales-Gonzáles JM; Benito-León J; Rivera-Navarro J; Mitchell AJ;
    Mult Scler; 2004 Feb; 10(1):47-54. PubMed ID: 14760952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proxy measurements in multiple sclerosis: agreement on different patient-reported outcome scales.
    Sonder JM; Bosma LV; van der Linden FA; Knol DL; Polman CH; Uitdehaag BM
    Mult Scler; 2012 Feb; 18(2):196-201. PubMed ID: 21908479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples.
    Riazi A; Hobart JC; Lamping DL; Fitzpatrick R; Thompson AJ
    J Neurol Neurosurg Psychiatry; 2002 Dec; 73(6):701-4. PubMed ID: 12438473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of multiple sclerosis condition-specific measures to inform health policy decision-making: mapping from the MSWS-12 to the EQ-5D.
    Hawton A; Green C; Telford CJ; Wright DE; Zajicek JP
    Mult Scler; 2012 Jun; 18(6):853-61. PubMed ID: 22108867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The validity, responsiveness, and score interpretation of the PROMISnq Physical Function - Multiple Sclerosis 15a short form in multiple sclerosis.
    Kamudoni P; Amtmann D; Johns J; Cook KF; Salem R; Salek S; Raab J; Middleton R; Repovic P; Alschuler KN; von Geldern G; Wundes A; Barrett A; Olayinka-Amao O; Henke C
    Mult Scler Relat Disord; 2022 Jun; 62():103753. PubMed ID: 35598408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome.
    Hobart JC; Riazi A; Lamping DL; Fitzpatrick R; Thompson AJ
    Health Technol Assess; 2004 Mar; 8(9):iii, 1-48. PubMed ID: 14982653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Validation of the FSIQ-RMS: A New Patient-Reported Questionnaire to Assess Symptoms and Impacts of Fatigue in Relapsing Multiple Sclerosis.
    Hudgens S; Schüler R; Stokes J; Eremenco S; Hunsche E; Leist TP
    Value Health; 2019 Apr; 22(4):453-466. PubMed ID: 30975397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [MusiQol: international questionnaire investigating quality of life in multiple sclerosis: validation results for the German subpopulation in an international comparison].
    Flachenecker P; Vogel U; Simeoni MC; Auquier P; Rieckmann P
    Nervenarzt; 2011 Oct; 82(10):1281-9. PubMed ID: 21472450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of the L-QoL: a quality-of-life instrument specific to systemic lupus erythematosus.
    Doward LC; McKenna SP; Whalley D; Tennant A; Griffiths B; Emery P; Veale DJ
    Ann Rheum Dis; 2009 Feb; 68(2):196-200. PubMed ID: 18385276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term impact of fampridine on motor and cognitive functions, mood and quality of life among multiple sclerosis patients.
    Pavsic K; Pelicon K; Ledinek AH; Sega S
    Clin Neurol Neurosurg; 2015 Dec; 139():35-40. PubMed ID: 26363365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The multiple sclerosis rating scale, revised (MSRS-R): development, refinement, and psychometric validation using an online community.
    Wicks P; Vaughan TE; Massagli MP
    Health Qual Life Outcomes; 2012 Jun; 10():70. PubMed ID: 22709981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefit evaluation in multiple sclerosis relapse treatment from the patients' perspective - Development and validation of a new questionnaire.
    Beckmann H; Augustin M; Heesen C; Poettgen J; Blome C
    Mult Scler Relat Disord; 2019 Feb; 28():256-261. PubMed ID: 30639826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of quality of life among patients with multiple sclerosis: an Italian cross-sectional study.
    Patti F; Russo P; Pappalardo A; Macchia F; Civalleri L; Paolillo A;
    J Neurol Sci; 2007 Jan; 252(2):121-9. PubMed ID: 17188301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. German translation, cultural adaptation and validation of the unidimensional self-efficacy scale for multiple sclerosis.
    Seebacher B; Mills RJ; Reindl M; Zamarian L; Kircher S; Brenneis C; Ehling R; Deisenhammer F
    BMC Neurol; 2021 Apr; 21(1):163. PubMed ID: 33865337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kurtzke scales revisited: the application of psychometric methods to clinical intuition.
    Hobart J; Freeman J; Thompson A
    Brain; 2000 May; 123 ( Pt 5)():1027-40. PubMed ID: 10775547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.